Iceland Business Times
SEE OTHER BRANDS

Your best source on business and economy news from Iceland

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland Business Times.

Too Lost Achieves No. 2 in Media & Entertainment and No. 7 NYC Placement on Inc. 5000 List

Too Lost Achieves No. 2 in Media & Entertainment and No. 7 NYC Placement on Inc. 5000 List

Too Lost music tech company in digital distribution and rights management, ranked #90 on the 2025 Inc. 5000 list of America’s fastest-growing private companies. NEW YORK, NY, UNITED STATES, August 28, 2025 /⁨EINPresswire.com⁩/ -- Too Lost, a music...

Tourism Source Market to Grow at a CAGR of 6.6% and will Reach USD 1.1 Trillion by 2032

Tourism Source Market to Grow at a CAGR of 6.6% and will Reach USD 1.1 Trillion by 2032

By tourist type, the group segment dominated the global market and is likely to remain dominant during the forecast period. WILMINGTON, DE, UNITED STATES, August 25, 2025 /⁨EINPresswire.com⁩/ -- The Tourism Source Market Size was valued at $599.40...

MyBTCX.com Adds SEPA Bank Transfers for Instant Euro & Global Crypto Purchases

MyBTCX.com Adds SEPA Bank Transfers for Instant Euro & Global Crypto Purchases

Eurozone and global users with SEPA-compatible banking can now fund crypto purchases quickly and securely on MyBTCX.com with low fees and non-custodial delivery SAN FRANCISCO, CA, UNITED STATES, August 25, 2025 /⁨EINPresswire.com⁩/ -- MyBTCX.com,...

Crusoe Expands Iceland Data Center Capacity with atNorth, Secures $175M Credit Facility from Victory Park Capital

Crusoe Expands Iceland Data Center Capacity with atNorth, Secures $175M Credit Facility from Victory Park Capital

SAN FRANCISCO, CHICAGO, and REYKJAVÍK, Iceland, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Crusoe, the industry’s first vertically integrated AI infrastructure provider, announced today with atNorth, a leading Nordic data center services provider, an...

Oculis Reports Q2 2025 Financial Results and Provides Company Update

Oculis Reports Q2 2025 Financial Results and Provides Company Update

Focused execution in Q2 2025 to advance Oculis’ pipeline in ophthalmology and neuro-ophthalmology OCS-01: Both pivotal Ph3 DIAMOND trials are fully enrolled, with topline results expected in Q2 2026 for the first potential eye drop to treat...

OG of fast cars drops in games: Porsche adopts in-car gaming with AirConsole

OG of fast cars drops in games: Porsche adopts in-car gaming with AirConsole

Zurich, Aug. 28, 2025 (GLOBE NEWSWIRE) -- AirConsole, the pioneering in-car gaming platform that transforms car rides into shared entertainment experiences, is arriving in the new Porsche Macan later this year. This collaboration will bring a...

The International Myeloma Foundation Revives ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2025

The International Myeloma Foundation Revives ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2025

STUDIO CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- With Blood Cancer Awareness Month coming up this September, the International Myeloma Foundation (IMF) is reviving and amplifying its highly successful #kNOwMyeloma campaign, centering on the...

Oculis to Participate in Upcoming September Investor Conferences

Oculis to Participate in Upcoming September Investor Conferences

ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant...

Axelyf Closes Seed Financing to Advance Next-Generation RNA-LNP Therapeutics

Axelyf Closes Seed Financing to Advance Next-Generation RNA-LNP Therapeutics

Icelandic venture capital firm Brunnur Ventures leads funding round to support development of breakthrough lipid nanoparticle delivery technologies BROOKLINE, MA, UNITED STATES, August 19, 2025 /⁨EINPresswire.com⁩/ -- Axelyf, Inc., a biotechnology...

Q2 2025 Financial Results

Q2 2025 Financial Results

Reykjavík, Aug. 14, 2025 (GLOBE NEWSWIRE) -- ("Amaroq" or the "Company") Q2 2025 Financial Results Maiden revenue and good operational progress across all commissioning activities at Nalunaq gold mine TORONTO, ONTARIO – 14 August 2025 – Amaroq...

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update

Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech’s history in terms of operating cash flows Continued expansion of commercial partnerships for pipeline assets Alvotech listed on Nasdaq...

Decentralized Methanol Plants Market is Expected to Reach a Valuation of USD 1,641 Million in 2035, Fact.MR Report

Decentralized Methanol Plants Market is Expected to Reach a Valuation of USD 1,641 Million in 2035, Fact.MR Report

Localized modular methanol plants transform fuel supply chains with low-emission production, integrating waste-to-energy, green hydrogen & carbon capture. ROCKVILLE, MD, UNITED STATES, August 12, 2025 /⁨EINPresswire.com⁩/ -- According to Fact.MR,...

Report states Western European companies over-dependent on great US tech

Report states Western European companies over-dependent on great US tech

(MENAFN) A new study by Swiss cloud firm Proton warns that Western European nations allied with the U.S. are overly dependent on American digital services, putting sensitive data at strategic risk. According to the report, 74% of publicly listed...

Century Aluminum Company Reports Second Quarter 2025 Results

Century Aluminum Company Reports Second Quarter 2025 Results

CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its second quarter 2025 results. Second Quarter 2025 Financial Results $MM (except shipments and per share data) Q2 2025 Q1 2025 Aluminum shipments...

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT

REYKJAVIK, Iceland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial...

Costco Wholesale Corporation Reports July Sales Results

Costco Wholesale Corporation Reports July Sales Results

ISSAQUAH, Wash., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $20.89 billion for the retail month of July, the four weeks ended August 3, 2025, an increase of...

BlueCat Networks unveils channel-first strategy with launch of BlueCatalyst Partner Program

BlueCat Networks unveils channel-first strategy with launch of BlueCatalyst Partner Program

TORONTO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- BlueCat Networks, a leader in Intelligent NetOps, today announced the launch of its channel-first BlueCatalyst Partner Program, which accelerates partner profitability with a robust, integrated DNS, DHCP,...

OneAdvanced supports Moran Logistics with new strategic partnership

OneAdvanced supports Moran Logistics with new strategic partnership

BIRMINGHAM, UNITED KINGDOM, August 27, 2025 /⁨EINPresswire.com⁩/ -- OneAdvanced, a leading provider of AI-powered, sector-focused software and IT services impacting 40 million lives daily, is pleased to announce a new strategic partnership with...

Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors

Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors

Mark Kupersmith, M.D. appointed as Chief Medical Advisor, Neuro-Ophthalmology, following positive Phase 2 ACUITY trial results with Privosegtor (OCS-05) in acute optic neuritis and initiation of multiple programs in neuro-ophthalmology Sebastian...

Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®

Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®

Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD) Approval is based on comprehensive analytical,...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions